Website profile

Pr Newswire

PR Newswire’s news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.

  • 5,918articles · 30d
  • 1+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 92%with images
  • 272avg words
articles per day
Categories
  • economy business and finance 2,779
  • FIB 2,220
  • NW 1,484
  • BI 783
  • science and technology 649
  • HW 602
  • HTH 558
  • arts culture entertainment and media 517

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@PRNewswire
prnewswire.com > news-releases > 60-million-americans-live-with-chronic-pain-us-pain-foundation-launches-onevoiceforpain-302865794.html

60 Million Americans Live With Chronic Pain: U.S. Pain Foundation Launches #OneVoiceForPain

1+ week, 5+ day ago   (265+ words) lived experience, data, and action to strengthen the collective voice of the pain community WEST HARTFORD, Conn., Sept. 1, 2026...their own. Yet across those differences, many share the same realities: struggling to be believed, searching...feeling isolated or unheard. This Pain…...

@PRNewswire
prnewswire.com > news-releases > sonex-health-announces-publication-of-largest-office-based-ultrasound-guided-carpal-tunnel-release-study-with-two-year-follow-up-302867276.html

SONEX HEALTH ANNOUNCES PUBLICATION OF LARGEST OFFICE-BASED ULTRASOUND-GUIDED CARPAL TUNNEL RELEASE STUDY WITH TWO-YEAR FOLLOW-UP

1+ week, 4+ day ago   (101+ words) include: This published data will further strengthen the UGCTR evidence base with 21 peer-reviewed publications...and educate physicians, patients and payors about the benefits of UGCTR. ABOUT SONEX HEALTH AND THE INSTITUTE OF ADVANCED ULTRASOUND GUIDED PROCEDURES...

@PRNewswire
prnewswire.com > news-releases > iflex-stretch-studios-adds-kinotek-3d-movement-technology-to-every-experience-302874396.html

iFlex Stretch Studios Adds Kinotek® 3D Movement Technology to Every Experience

3+ day, 15+ hour ago   (256+ words) markers, sensors, or wearables required. In seconds, the technology analyzes range of motion, symmetry, and...therapists a second set of eyes. It shows them things the human eye may miss and gives clients a clear way...session." For clients, Kinotek…...

@PRNewswire
prnewswire.com > news-releases > joy-organics-expands-organic-thc-free-cbd-gummy-line-with-new-50mg-strength-and-sour-apple-flavor-302858997.html

Joy Organics Expands Organic THC-Free CBD Gummy Line With New 50mg Strength and Sour Apple Flavor

2+ week, 5+ day ago   (184+ words) Aug 25, 2026, 07:00 ET The new 50mg option delivers Joy Organics' highest-strength USDA-Certified...CBD gummy collection with a new 50mg strength and the introduction of sour apple, a brand-new flavor. The new gummies contain 50mg of broad spectrum CBD per...Organics' existing THC-free CBD gummy…...

@PRNewswire
prnewswire.com > news-releases > in-hellonation-physical-therapy-expert-dr-kali-spoto-larue-explains-how-physical-therapy-supports-back-and-neck-pain-relief-302855350.html

In HelloNation, Physical Therapy Expert Dr. Kali Spoto LaRue Explains How Physical Therapy Supports Back and Neck Pain Relief

3+ week, 4+ day ago   (203+ words) Aug 19, 2026, 10:16 ET The article explains how physical therapy improves mobility, flexibility,...Posture education is another major focus discussed in the article. Prolonged and poor posture while sitting,...electronic devices can place accumulated stress. The article explains that physical therapists help…...

@PRNewswire
prnewswire.com > news-releases > aft-pharmaceuticals-partners-with-mark-cuban-cost-plus-marketplace-to-bring-the-new-non-opioid-pain-medication-combogesic-to-the-us-302872553.html

partners with Mark Cuban Cost Plus Marketplace to bring the new non-opioid pain medication, Combogesic® to the U.S.

4+ day, 22+ hour ago   (253+ words) 08, 2026, 12:16 ET That philosophy extends beyond the medicine itself. Through their partnership with the Mark Cuban Cost Plus Marketplace", AFT Pharmaceuticals...Combogesic accessible and affordable to patients across the United States. As pain management continues to evolve,...patients are looking for…...

@PRNewswire
prnewswire.com > news-releases > spear-physical--occupational-therapys-jeremy-crow-named-2026-apta-new-york-physical-therapist-of-the-year-302854833.html

Occupational Therapy's Jeremy Crow Named 2026 APTA New York Physical Therapist of the Year

3+ week, 4+ day ago   (523+ words) Crow Named 2026 APTA New York Physical Therapist of the Year PR Newswire Since joining Spear in 2015, Crow has helped expand the organization's nationally recognized residency...education. "This award is really a reflection of the people I'm fortunate to work with…...

@PRNewswire
prnewswire.com > news-releases > professional-physical-therapy-launches-rise-program-to-help-physical-therapists-repay-student-loans-302866756.html

Professional Physical Therapy Launches RISE Program to Help Physical Therapists Repay Student Loans

1+ week, 4+ day ago   (353+ words) current and future physical therapists overcome one of the profession's most significant barriers: student...year of full-time employment, up to: $5,000 after the first year, $7,500 after the second, $10,000 after the third, $12,500 after the fourth and $15,000 after the fifth, a total potential…...

@PRNewswire
prnewswire.com > news-releases > vascarta-outlines-vas-101s-vasceptor-potential-as-a-non-opioid-advance-in-pain-medicine-across-sickle-cell-disease-osteoarthritis-and-cancer-302858963.html

Vascarta Outlines VAS-101's (Vasceptor®) Potential as a Non-Opioid Advance in Pain Medicine Across Sickle Cell Disease, Osteoarthritis, and Cancer

2+ week, 5+ day ago   (157+ words) ingredient such as curcumin, is designed to cross the skin and reach plasma and circulating blood cells for both local and systemic effect — without the bioavailability limits of oral dosing or the burdens of intravenous administration [1]. Vascarta...neuropathy in a…...

@PRNewswire
prnewswire.com > news-releases > pleopharma-awarded-6-5-million-nida-grant-to-support-phase-3-trial-of-pp-01-for-cannabis-withdrawal-in-patients-with-cannabis-use-disorder-302856379.html

PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for Cannabis Withdrawal in Patients with Cannabis Use Disorder

3+ week, 3+ day ago   (143+ words) use disorder These successful results have paved the way for CAN-004, the ongoing pivotal Phase 3 trial, with the first patient dosed in June 2026. The study is evaluating the safety and efficacy of PP-01 in adults with moderate...Research noted in…...

Web

External web results are waiting for the human check. Complete the press-and-hold control above. Google advertising and AI choices remain separate after verification.